🏢 官网IRPMQwen · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 09-08(美东日)仅日期·⟳ 抓取 09-08 21:57:45回填·⚡ 决策 09-09 07:37:59·48.8 天前
菲利普莫里斯国际（PM.US）在巴克莱全球消费品会议上以Reg FD提交8-K并附CEO幻灯片，仅因汇率将2026年调整后EPS指引上调至8.35–8.50美元，经营假设与剔除汇率后7.5%–9.5%的增速口径维持7月22日不变
跨源查重命中同一具体催化的两条已处理记录（09-08 12:32 UTC sec_edgar 的 8-K/EX-99.1 新闻稿、09-08 12:37 UTC twitter 指引快讯，结论均为不做）；本次ir_page来源为同一份8-K的幻灯片全文，比对后未出现任何新增金额、指引再修正、官方确认/否认或监管进展，仅有『符合预期』的经营确认与Q4包装规格调整。同时该指引上调在实质上无基本面增量（剔除汇率后增速与美元区间不变），对超大市值成熟消费主标的属典型软催化；披露发生在美东盘前、当日整个盘中已消化，now=19:35 ET盘后不可成交，可执行窗口亦已关闭。故按查重+无增量事实直接AVOID，未再展开Web/KB/行情/先例研究。
📄 原文PM↗ 原文
Report of unscheduled material events or corporate event
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13…
不做 Philip Morris International（PM.US）
同一具体催化已在09-08 12:32 UTC（sec_edgar 8-K/EX-99.1）与12:37 UTC（twitter 指引快讯）两次处理并判不做；本次ir_page来源为同稿幻灯片全文，无新增金额、指引修正、官方确认或监管进展。实质上调100%来自汇率（24美分），剔除汇率后2026年adjusted EPS仍为8.11–8.26美元、增速7.5%–9.5%，经营假设与7月22日口径完全一致；日本IQOS offtake复苏『符合预期』、10月提价已确认、美国Z…
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
事实：PMI于2026-09-08就巴克莱全球消费品会议furnish 8-K Item 7.01，附CEO演示幻灯片，把2026年adjusted diluted EPS指引由8.26–8.41美元上调到8.35–8.50美元（+10.7%–12.7%），Q3由2.20–2.25美元上调到2.29–2.34美元，但公司在标题与附注中明确写明上调『仅因汇率』（24美分有利汇率），剔除汇率后区间仍为8.11–8.26美元、增速7.5%–9.5%，与2025年7.54美元基数下的原口径一致。影响链：汇率换算型上调不改变销量、价格、毛利率、费用或产能假设，也不改变无烟产品（IQOS/VEEV/ZYN）的需求斜率；幻灯片其余内容为日本offtake复苏符合预期、10月提价已确认、美国ZYN Q4转20袋/罐的包装规格调整——均为既有计划的确认，无新增收入或利润事实。价格/证据：本臂跨源查重命中同一催化的两条已处理记录（sec_edgar 12:32 UTC、twitter 12:37 UTC，均判不做），本次为同稿IR镜像；披露落在美东盘前，当日09:30–16:00盘中已完成消化，now为19:35 ET盘后不可成交。结论：对约2500亿美元市值的成熟消费主标的，这是无金额增量的软催化且属重复消息，无正期望、无可执行窗口，AVOID；事件本身非净利空，risk_signals为空。
🔎 新鲜度:最早出现 2026-09-08 · 扩散 medium · price-in 风险 high ↗
关键理由
- 指引上调100%来自汇率换算（24美分），剔除汇率后的美元区间与增速口径未变，不构成经营层面的预期差
- 同一具体催化已在09-08 12:32 UTC（sec_edgar）与12:37 UTC（twitter）两次处理并判不做，本次IR幻灯片无新增事实
- PM为超大市值成熟消费股，软催化相对市值的增量过小，且披露于美东盘前、当日盘中已消化，现已盘后不可成交
主要风险
- 若后续Q3实际经营口径（IQOS日本offtake、ZYN美国规格转换后的量价）出现偏离『符合预期』的下修，才会形成新的方向性事实，本次幻灯片不包含该风险
- 汇率驱动的账面EPS上调若被市场误读为基本面上修，可能带来短暂情绪溢价，但对PM这类高指数权重股通常在当日盘中即被套利消化
反向证据
- 做多前查反向 · 来源 search_processed_events · 日期 2026-09-08 · 影响 invalidates
命中同一具体催化的两条已处理记录：09-08 12:32 UTC sec_edgar（8-K/EX-99.1，结论不做，理由为EPS上调仅反映汇率、经营假设未变）与09-08 12:37 UTC twitter（Q3 2.29–2.34、FY 8.35–8.50 快讯，结论不做，理由为汇率驱动小幅上修、量级不足）；本次幻灯片全文未提供新增金额、指引再修正、官方确认/否认或监管进展
检索:PMI 上调2026年调整后EPS指引 / Barclays Global Consumer Conference Olczak webcast slides / ZYN 20 pouches per can Q4 transition / IQOS Japan offtake October pricing（sear 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例缺失不改变结论：AVOID的依据是重复消息与无基本面增量，而非幅度不足
方向:未做外部先例统计：本条已命中同一具体催化的已处理记录且无新增事实，按查重早停路径结束
涨幅量级:无高相似先例用于校准幅度；即使有，汇率型指引上调（剔除汇率口径不变）在超大市值成熟股上通常不产生可交易幅度
形态:无先例数据；从传播结构看，盘前一手披露+当日全日盘中消化，属典型『开盘前明牌、当日price-in』形态，追高见光死风险高于继续上行
工具执行结果 · 成功 2 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 75 ms
{"result": "search_processed_events:agent query=`iqos japan offtake recovery october pricing | philip morris international pmi 上调2026年调整后eps指引 | pm 8-k item 7.01 regulation fd 投资者会议幻灯片 | pmi barclays global consumer conference ol`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 67.0/72 小时、999 条本臂决策(完整)，返回 2 条候选。\n• 09-08 - fetch_decision_experience 成功 stock_tools HTTP · 10 ms
{
原文全文
展开原文 · 15,222 字
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 8, 2026
Philip Morris International Inc.
(Exact name of registrant as specified in its charter)
Virginia 1-33708 13-3435103
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
677 Washington Blvd, Ste.
1100 Stamford Connecticut 06901
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (203) 905-2410
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value PM New York Stock Exchange
3.125% Notes due 2027 PM27 New York Stock Exchange
3.125% Notes due 2028 PM28 New York Stock Exchange
2.875% Notes due 2029 PM29 New York Stock Exchange
3.375% Notes due 2029 PM29A New York Stock Exchange
2.750% Notes due 2029 PM29D New York Stock Exchange
3.750% Notes due 2031 PM31B New York Stock Exchange
0.800% Notes due 2031 PM31 New York Stock Exchange
3.250% Notes due 2032 PM32 New York Stock Exchange
3.125% Notes due 2033 PM33 New York Stock Exchange
2.000% Notes due 2036 PM36 New York Stock Exchange
1.875% Notes due 2037 PM37A New York Stock Exchange
6.375% Notes due 2038 PM38 New York Stock Exchange
1.450% Notes due 2039 PM39 New York Stock Exchange
4.375% Notes due 2041 PM41 New York Stock Exchange
4.500% Notes due 2042 PM42 New York Stock Exchange
3.875% Notes due 2042 PM42A New York Stock Exchange
4.125% Notes due 2043 PM43 New York Stock Exchange
4.875% Notes due 2043 PM43A New York Stock Exchange
4.250% Notes due 2044 PM44 New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised ☐
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01. Regulation FD Disclosure.
On September 8, 2026, Philip Morris International Inc. (“PMI”) is hosting a live audio webcast of a presentation and question-and-answer session by Jacek Olczak, Group CEO PMI,
at the Barclays Global Consumer Conference. In connection with the webcast, PMI is furnishing to the Securities and Exchange Commission the webcast slides attached as Exhibit
99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report on Form 8-K shall not be
incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as may be expressly set forth by specific reference in such
filing or document.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Philip Morris International Inc. Webcast Slides, dated September 8, 2026 (furnished pursuant to Item 7.01).
104 Cover Page Interactive Data File (formatted in Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PHILIP MORRIS INTERNATIONAL INC.
By: /s/ DARLENE QUASHIE HENRY
Name: Darlene Quashie Henry
Title: Vice President, Associate General Counsel & Corporate Secretary
Date: September 8, 2026
Championing a Smoke-Free World Barclays Global Consumer Conference September 8, 2026 Jacek Olczak Group CEO PMI Introduction • A glossary of terms as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available in Exhibits 99.2 to the company's Form 8-K dated February 6, 2026 and July 22, 2026 and on our Investor Relations website 2 Exhibit 99.1
Forward-Looking and Cautionary Statements • This presentation contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI • PMI's business risks include: marketing and regulatory restrictions that could reduce our competitiveness, disrupt our SFP commercialization efforts, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; excise tax increases and discriminatory tax structures; health concerns relating to the use of tobacco and other nicotine-containing products; litigation related to tobacco and/or nicotine products and intellectual property rights; intense competition; inability to anticipate changes in adult consumer preferences; use and reliance on third-parties; the adverse effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; geopolitical instability; the impact and consequences of Russia's invasion of Ukraine; changes in legal-age smoker behavior; continue
decline of tax-paid cigarettes; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, sustained periods of elevated inflation, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; disruptions in the credit markets or changes to its credit ratings; recent and potential future tariffs imposed by the U.S. and other countries; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as product components for its electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful, in key markets or systemically, in its efforts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, and promote brand equity; if there are prolonged disruptions of facilities used to produce its products; if it is unable to enter new markets or improve its margins through increased prices and productivity gains; if other market participants are more successful in their SFP commercialization efforts; if it is unable to attract and retain the best global talent; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products performance • PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year
ended December 31, 2025 and the Form 10-Q for the quarter ended June 30, 2026. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations • References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., including its subsidiaries 3 On Track for Another Strong Year of Growth • Raising 2026 adj. diluted EPS forecast for currency only to $8.35 - $8.50, or 10.7% to 12.7% growth, incl. favorable currency impact of 24 cents(a)⎼ Includes Q3 adj. diluted EPS forecast of $2.29 to $2.34, with 1 cent(a) favorable currency • IQOS continues to drive broad-based smoke-free growth:⎼ Japan consumer offtake recovery in line with expectations, October pricing confirmed ⎼ Strong multicategory growth in international markets incl. VEEV, ZYN • Expanding U.S. ZYN range and aligning value proposition across ZYN portfolio with Q4 transition of 3mg and 6mg dry variants to 20 pouches/can • Continued robust performance from combustibles as expected, notably in markets with bans or limited presence of SFPs 4 (a) At prevailing exchange rates. Source: PMI financials or estimates
Championing a Smoke-Free World Barclays Global Consumer Conference September 8, 2026 6 Appendix
2026: EPS Guidance 7 (a) Includes: $0.10 Germany excise tax classification litigation charge; ($0.10) RBH (Canada) Plan Implementation, including dividend income, net; $0.09 Impairment of Wellness business related equity investment; $0.06 Loss on expected sale of consumer accessories and other businesses; $0.03 Impairment of goodwill; ($0.11) Tax items Source: PMI financials or estimates Growth2025 2026 Forecast $7.26$7.28 – $7.43Reported Diluted EPS Adjustments: 0.500.50- Amortization of intangibles (0.18)0.16- Fair value adjustment for equity investments 0.140.03- Restructuring charges (0.25)0.06- Income tax impact associated with Swedish Match AB financing -0.33- Non-cash impairment of RBH equity investment -(0.01)- Egypt sales tax settlement adjustment 0.07-- Other 2025 adjustments(a) 0.281.07- Total Adjustments 10.7% – 12.7%$7.54$8.35 – $8.50Adjusted Diluted EPS 0.24- Less: Currency 7.5% – 9.5%$7.54$8.11 – $8.26Adjusted Diluted EPS, excluding currency ($/share) Championing a Smoke-Free World Barclays Global Consumer Conference September 8, 2026
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 8, 2026
Philip Morris International Inc.
(Exact name of registrant as specified in its charter)
Virginia 1-33708 13-3435103
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
677 Washington Blvd, Ste.
1100 Stamford Connecticut 06901
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (203) 905-2410
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value PM New York Stock Exchange
3.125% Notes due 2027 PM27 New York Stock Exchange
3.125% Notes due 2028 PM28 New York Stock Exchange
2.875% Notes due 2029 PM29 New York Stock Exchange
3.375% Notes due 2029 PM29A New York Stock Exchange
2.750% Notes due 2029 PM29D New York Stock Exchange
3.750% Notes due 2031 PM31B New York Stock Exchange
0.800% Notes due 2031 PM31 New York Stock Exchange
3.250% Notes due 2032 PM32 New York Stock Exchange
3.125% Notes due 2033 PM33 New York Stock Exchange
2.000% Notes due 2036 PM36 New York Stock Exchange
1.875% Notes due 2037 PM37A New York Stock Exchange
6.375% Notes due 2038 PM38 New York Stock Exchange
1.450% Notes due 2039 PM39 New York Stock Exchange
4.375% Notes due 2041 PM41 New York Stock Exchange
4.500% Notes due 2042 PM42 New York Stock Exchange
3.875% Notes due 2042 PM42A New York Stock Exchange
4.125% Notes due 2043 PM43 New York Stock Exchange
4.875% Notes due 2043 PM43A New York Stock Exchange
4.250% Notes due 2044 PM44 New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised ☐
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01. Regulation FD Disclosure.
On September 8, 2026, Philip Morris International Inc. (“PMI”) is hosting a live audio webcast of a presentation and question-and-answer session by Jacek Olczak, Group CEO PMI,
at the Barclays Global Consumer Conference. In connection with the webcast, PMI is furnishing to the Securities and Exchange Commission the webcast slides attached as Exhibit
99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report on Form 8-K shall not be
incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as may be expressly set forth by specific reference in such
filing or document.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 Philip Morris International Inc. Webcast Slides, dated September 8, 2026 (furnished pursuant to Item 7.01).
104 Cover Page Interactive Data File (formatted in Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PHILIP MORRIS INTERNATIONAL INC.
By: /s/ DARLENE QUASHIE HENRY
Name: Darlene Quashie Henry
Title: Vice President, Associate General Counsel & Corporate Secretary
Date: September 8, 2026
Championing a Smoke-Free World Barclays Global Consumer Conference September 8, 2026 Jacek Olczak Group CEO PMI Introduction • A glossary of terms as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available in Exhibits 99.2 to the company's Form 8-K dated February 6, 2026 and July 22, 2026 and on our Investor Relations website 2 Exhibit 99.1
Forward-Looking and Cautionary Statements • This presentation contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI • PMI's business risks include: marketing and regulatory restrictions that could reduce our competitiveness, disrupt our SFP commercialization efforts, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; excise tax increases and discriminatory tax structures; health concerns relating to the use of tobacco and other nicotine-containing products; litigation related to tobacco and/or nicotine products and intellectual property rights; intense competition; inability to anticipate changes in adult consumer preferences; use and reliance on third-parties; the adverse effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; geopolitical instability; the impact and consequences of Russia's invasion of Ukraine; changes in legal-age smoker behavior; continue
decline of tax-paid cigarettes; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, sustained periods of elevated inflation, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; disruptions in the credit markets or changes to its credit ratings; recent and potential future tariffs imposed by the U.S. and other countries; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as product components for its electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful, in key markets or systemically, in its efforts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, and promote brand equity; if there are prolonged disruptions of facilities used to produce its products; if it is unable to enter new markets or improve its margins through increased prices and productivity gains; if other market participants are more successful in their SFP commercialization efforts; if it is unable to attract and retain the best global talent; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products performance • PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year
ended December 31, 2025 and the Form 10-Q for the quarter ended June 30, 2026. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations • References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., including its subsidiaries 3 On Track for Another Strong Year of Growth • Raising 2026 adj. diluted EPS forecast for currency only to $8.35 - $8.50, or 10.7% to 12.7% growth, incl. favorable currency impact of 24 cents(a)⎼ Includes Q3 adj. diluted EPS forecast of $2.29 to $2.34, with 1 cent(a) favorable currency • IQOS continues to drive broad-based smoke-free growth:⎼ Japan consumer offtake recovery in line with expectations, October pricing confirmed ⎼ Strong multicategory growth in international markets incl. VEEV, ZYN • Expanding U.S. ZYN range and aligning value proposition across ZYN portfolio with Q4 transition of 3mg and 6mg dry variants to 20 pouches/can • Continued robust performance from combustibles as expected, notably in markets with bans or limited presence of SFPs 4 (a) At prevailing exchange rates. Source: PMI financials or estimates
Championing a Smoke-Free World Barclays Global Consumer Conference September 8, 2026 6 Appendix
2026: EPS Guidance 7 (a) Includes: $0.10 Germany excise tax classification litigation charge; ($0.10) RBH (Canada) Plan Implementation, including dividend income, net; $0.09 Impairment of Wellness business related equity investment; $0.06 Loss on expected sale of consumer accessories and other businesses; $0.03 Impairment of goodwill; ($0.11) Tax items Source: PMI financials or estimates Growth2025 2026 Forecast $7.26$7.28 – $7.43Reported Diluted EPS Adjustments: 0.500.50- Amortization of intangibles (0.18)0.16- Fair value adjustment for equity investments 0.140.03- Restructuring charges (0.25)0.06- Income tax impact associated with Swedish Match AB financing -0.33- Non-cash impairment of RBH equity investment -(0.01)- Egypt sales tax settlement adjustment 0.07-- Other 2025 adjustments(a) 0.281.07- Total Adjustments 10.7% – 12.7%$7.54$8.35 – $8.50Adjusted Diluted EPS 0.24- Less: Currency 7.5% – 9.5%$7.54$8.11 – $8.26Adjusted Diluted EPS, excluding currency ($/share) Championing a Smoke-Free World Barclays Global Consumer Conference September 8, 2026
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。